Skip to main content

ADVERTISEMENT

antiemetic

Research in Review
12/11/2015
JCP Editors
The American Society of Clinical Oncology (ASCO) issued updated antiemetic guidelines recommending that patients who receive highly emetogenic chemotherapy regimens be offered a 3-drug combination of a neurokinin 1...
The American Society of Clinical Oncology (ASCO) issued updated antiemetic guidelines recommending that patients who receive highly emetogenic chemotherapy regimens be offered a 3-drug combination of a neurokinin 1...
The...
12/11/2015
Journal of Clinical Pathways